SCA
AMPE

Stonebridge Capital Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Stonebridge Capital Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4
Closed -$15 – 920
2023
Q3 		$15 Buy
+4
New +$17 ﹤0.01% 921
2020
Q3 		– Sell
-17
Closed -$3K – 767
2020
Q2 		$3K Hold
17
– – ﹤0.01% 642
2020
Q1 		$2K Hold
17
– – ﹤0.01% 677
2019
Q4 		$3K Hold
17
– – ﹤0.01% 713
2019
Q3 		$3K Hold
17
– – ﹤0.01% 692
2019
Q2 		$2K Buy
+17
New +$2.69K ﹤0.01% 804

Other funds holding AMPE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stonebridge Capital Advisors's AMPE Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2023, closing a stake of 4 shares — an estimated $15 sold.

Stonebridge Capital Advisors first reported a position in AMPE in Q2 2019 and held it in 6 quarters. The position peaked at $3K in Q2 2020. 29 funds tracked by Wall St. Rank hold AMPE as of Q4 2023.

  • Stonebridge Capital Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
  • Stonebridge Capital Advisors sold 4 Ampio Pharmaceuticals Inc. shares in Q4 2023, an estimated $15.
  • Stonebridge Capital Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q2 2019 and held it in 6 quarters.
  • Stonebridge Capital Advisors's Ampio Pharmaceuticals Inc. position peaked at $3K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.